JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) EV-to-Revenue : 1.09 (As of May. 24, 2024)

JW (Cayman) Therapeutics Co EV-to-Revenue Chart

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial						90.06	-	3.41	-	0.95

Competitive Comparison of JW (Cayman) Therapeutics Co's EV-to-Revenue

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's EV-to-Revenue falls into.

JW (Cayman) Therapeutics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

JW (Cayman) Therapeutics Co's EV-to-Revenue for today is calculated as:

JW (Cayman) Therapeutics Co's current Enterprise Value is $25.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JW (Cayman) Therapeutics Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $23.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW (Cayman) Therapeutics Co  (OTCPK:JWCTF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

JW (Cayman) Therapeutics Co's PS Ratiofor today is calculated as:

JW (Cayman) Therapeutics Co's share price for today is $0.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW (Cayman) Therapeutics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description